Home >Science >Health >India's covid vaccine: Phase-3 trial of Covaxin to soon begin in UP's Lucknow
The human trials of Covaxin has begun at the All India Institute of Medical Sciences, Patna
The human trials of Covaxin has begun at the All India Institute of Medical Sciences, Patna

India's covid vaccine: Phase-3 trial of Covaxin to soon begin in UP's Lucknow

The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.

The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.

"The phase-3 trial of COVAXIN being developed by Bharat Biotech will start in Lucknow and Gorakhpur from October," said Uttar Pradesh Principal Health Secretary Amit Mohan Prasad here in a press conference.

The Indian Council for Medical Research (ICMR) is collaborating with Bharat Biotech for the development of the COVAXIN.

Meanwhile, Congress leader Deepak Singh on Thursday wrote a letter to Chief Minister Yogi Adityanath and requested to increase testing for COVID-19 in Uttar Pradesh.

According to the Union Health Ministry as of Thursday, there are 61,698 active cases in the state with 3,02,689 recovered people and 5,299 deaths.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
x
×
My Reads Redeem a Gift Card Logout